August 14, 2017 / 10:18 AM / 2 years ago

BRIEF-Soligenix receives $2.5 mln in additional Niaid funding to advance development of heat stable ricin vaccine

Aug 14 (Reuters) - Soligenix Inc

* Soligenix receives $2.5m in additional Niaid funding to advance development of heat stable ricin vaccine

* Soligenix Inc - ‍National Institute of Allergy and Infectious Diseases has exercised an option to fund good manufacturing practices compliant rivax​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below